These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 6820620

  • 1. [New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
    Touboul P, Kirkorian G, Atallah G, Moleur P.
    Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):531-7. PubMed ID: 6820620
    [No Abstract] [Full Text] [Related]

  • 2. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A.
    Am J Cardiol; 1983 Sep 22; 52(6):24C-31C. PubMed ID: 6414279
    [Abstract] [Full Text] [Related]

  • 3. New drugs in the management of ventricular arrhythmias.
    Sanna GP.
    G Ital Cardiol; 1984 Oct 22; 14(10):788-97. PubMed ID: 6083894
    [Abstract] [Full Text] [Related]

  • 4. Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
    Camm AJ.
    Eur Heart J; 1984 Sep 22; 5 Suppl B():75-9. PubMed ID: 6437820
    [No Abstract] [Full Text] [Related]

  • 5. Clinical pharmacology of old and new antiarrhythmic drugs.
    Siddoway LA, Roden DM, Woosley RL.
    Cardiovasc Clin; 1985 Sep 22; 15(3):199-248. PubMed ID: 2870805
    [Abstract] [Full Text] [Related]

  • 6. Haemodynamic effects of encainide, flecainide, lorcainide and tocainide.
    Vanhaleweyk G, Serruys PW, Hugenholtz PG.
    Eur Heart J; 1984 Sep 22; 5 Suppl B():67-74. PubMed ID: 6437819
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
    Podrid PJ.
    Chest; 1985 Oct 22; 88(4):618-24. PubMed ID: 3930162
    [No Abstract] [Full Text] [Related]

  • 9. [New anti-arrhythmia drugs].
    Vidal Garate J, Romero-Ayala LC, Cárdenas Loaeza M.
    Arch Inst Cardiol Mex; 1983 Oct 22; 53(2):159-78. PubMed ID: 6411015
    [Abstract] [Full Text] [Related]

  • 10. Clinical pharmacology of antiarrhythmic agents.
    Kelliher GJ, Kowey P, Engel T, Wetstein L.
    Cardiovasc Clin; 1985 Oct 22; 16(1):287-305. PubMed ID: 2874883
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW, Hammill SC.
    Mayo Clin Proc; 1987 Nov 22; 62(11):1033-50. PubMed ID: 3118116
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The effect of anti-arrhythmic drugs on myocardial function (author's transl)].
    Wester HA, Mouselimis N.
    Dtsch Med Wochenschr; 1982 Aug 27; 107(34):1262-6. PubMed ID: 6809442
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
    Hellestrand KJ.
    Eur Heart J; 1984 Sep 27; 5 Suppl B():87-94. PubMed ID: 6437822
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.